Sildenafil Citrate to Improve Maternal and Neonatal Outcomes in Low-resource Settings

CompletedOBSERVATIONAL
Enrollment

1,017

Participants

Timeline

Start Date

May 16, 2023

Primary Completion Date

October 30, 2023

Study Completion Date

December 31, 2023

Conditions
Fetal DistressPerinatal AsphyxiaBirth AsphyxiaStillbirth
Trial Locations (1)

Unknown

University Teaching Hospital, Lusaka

All Listed Sponsors
collaborator

Global Network for Women's and Children's Health Research

OTHER

collaborator

University of Alabama at Birmingham

OTHER

collaborator

University Teaching Hospital, Lusaka, Zambia

OTHER

collaborator

RTI International

OTHER

lead

NICHD Global Network for Women's and Children's Health

NETWORK

NCT05946681 - Sildenafil Citrate to Improve Maternal and Neonatal Outcomes in Low-resource Settings | Biotech Hunter | Biotech Hunter